Investigating biomarkers of Staphylococcus aureus bacteremia in patients - School of Pharmacy

The Centers for Disease Control identifies methicillin-resistant S. aureus (MRSA) as a serious health threat with greater than 100,000 invasive infections and 20,000 patient deaths annually in the United States. Despite recent advancements in available treatment options for methicillin-sensitive S.

Staph Aureus Bacteremia — The Intern at Work

Suggested approach for the evaluation of patients with S. aureus

Therapy of Staphylococcus aureus bacteremia: Evidences and challenges Enfermedades Infecciosas y Microbiología Clínica (English Edition)

Frontiers Practice Summary of Antimicrobial Therapy for Commonly Encountered Conditions in the Neonatal Intensive Care Unit: A Canadian Perspective

Frontiers Management of Staphylococcus aureus Bloodstream Infections

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Antibiotic shows efficacy against complicated Staph bacteremia

Investigational agents for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: progress in clinical trials: Expert Opinion on Investigational Drugs: Vol 31, No 3

Rapid detection of Staphylococcus aureus and Streptococcus pneumoniae by real-time analysis of volatile metabolites - ScienceDirect